16th January 2007

 

Stockport LMC can therefore announce Solvay as its primary supplier for the flu purchase consortium this year.

Solvay will therefore supply their imuvac product (£6.59 NHS price) to secure a net income to practice of approximately £6.37 per dose including an estimated dispensing fee of £2.34.

 

Our secondary supplier this year Wyeth, will supply their Enzira product  to those practices where a rebate cannot be agreed which will return a profit of approximately £6.02 per dose including the same estimated dispensing fee.

 

The letter available via this link has been sent to Stockport Practices this week

Practices will notice that the suppliers will contact practices direct this year for orders.